Methods and Compositions for Sequencing Complementary Polynucleotides
Singular Genomics Systems, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 63/183,585, filed May 3, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,913,071 | Methods and Compositions for Sequencing Complementary Polynucleotides In force · High confidence UsedRemaining | Singular Genomics Systems, Inc. | In force | High confidence | ||
| US 11,486,001 | Methods and Compositions for Sequencing Complementary Polynucleotides In force · High confidence | Singular Genomics Systems, Inc. | In force | High confidence | ||
| US 11,560,590 | Methods and Compositions for Sequencing Complementary Polynucleotides In force · High confidence | Singular Genomics Systems, Inc. | In force | High confidence | ||
| US 11,788,133 | Methods and Compositions for Sequencing Complementary Polynucleotides In force · High confidence | Singular Genomics Systems, Inc. | In force | High confidence | ||
| Application 17/934,425 | Methods and Compositions for Sequencing Complementary Polynucleotides Pending Not granted | Singular Genomics Systems, Inc. | Pending | Not granted | ||
| Application 18/413,603 | Methods and Compositions for Sequencing Complementary Polynucleotides Pending Not granted | Singular Genomics Systems, Inc. | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Singular Genomics Systems, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.